Eloxx Pharmaceuticals, Inc. (ELOX) vs Zhengye Biotechnology Holding Limited (ZYBT)
A side-by-side comparison of Eloxx Pharmaceuticals, Inc. and Zhengye Biotechnology Holding Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELOX
Eloxx Pharmaceuticals, Inc.
$15.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZYBT
Zhengye Biotechnology Holding Limited
$1.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ELOX vs ZYBT
growth of $100 · dividends reinvested · last 1yELOX +40.0% (+40.0%/yr)ZYBT +33.6% (+33.6%/yr)ELOX compounded faster over this window
ELOX ZYBT
Metrics side by side
Total return (annualized)
| Metric | ELOX | ZYBT |
|---|---|---|
| Total return (1Y) | N/A | -55.42% |
ELOX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.